BrachytherapyRadiotherapy DosageRadiotherapyIridium RadioisotopesRadiotherapy, AdjuvantRadiotherapy, ConformalRadiotherapy Planning, Computer-AssistedChemotherapy, AdjuvantAdjuvants, ImmunologicCombined Modality TherapyRadiation InjuriesDose FractionationRadiotherapy, Intensity-ModulatedRadiotherapy, High-EnergyRadiotherapy, Image-GuidedRadiotherapy, Computer-AssistedTreatment OutcomeProstatic NeoplasmsNeoplasm Recurrence, LocalDose-Response Relationship, RadiationRadiometryFreund's AdjuvantRadiation OncologyNeoplasm StagingDisease-Free SurvivalRuthenium RadioisotopesUterine Cervical NeoplasmsRetrospective StudiesOrgans at RiskVaginal NeoplasmsFollow-Up StudiesSurvival RateRadiation DosageRadiosurgerySurvival AnalysisBreast NeoplasmsNasopharyngeal NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsChemoradiotherapyCarcinoma, Squamous CellIodine RadioisotopesBeta ParticlesMastectomy, SegmentalPrognosisHead and Neck NeoplasmsTomography, X-Ray ComputedRadioisotope TeletherapyBrain NeoplasmsAdjuvants, PharmaceuticRectumChoroid NeoplasmsAdenocarcinomaPelvic NeoplasmsTongue NeoplasmsLung NeoplasmsTime FactorsRectal NeoplasmsCisplatinSarcomaAndrogen AntagonistsRectal DiseasesPalliative CareNeoadjuvant TherapyFluorouracilYtterbiumLymphatic IrradiationProstate-Specific AntigenMagnetic Resonance Imaging, InterventionalKaplan-Meier EstimateAntineoplastic Agents, HormonalFiducial MarkersFat NecrosisRadiation ToleranceRadioisotopesCarcinomaProspective StudiesProstatectomyAntineoplastic AgentsUrination DisordersUveal NeoplasmsRadiation ProtectionGenital Neoplasms, FemaleUrinary RetentionLymphatic MetastasisFeasibility StudiesStrontium RadioisotopesRadiation-Sensitizing AgentsNeoplasms, Second PrimaryPelvisSalvage TherapyHistiocytomaPhantoms, ImagingParticle AcceleratorsRelative Biological EffectivenessOsteoradionecrosisCranial IrradiationTumor BurdenCobalt RadioisotopesGlossectomySoft Tissue Neoplasms